George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 250,000 shares at $46.89 ($11.7M) on 2021-03-02, disclosed to the SEC on 2021-03-04.
Open-market sale of $11.7M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.89 | 96,490 | $4.5M | 38.6% |
| 2 | $46.89 | 22,375 | $1.0M | 8.9% |
| 3 | $46.89 | 22,375 | $1.0M | 8.9% |
| 4 | $46.89 | 96,490 | $4.5M | 38.6% |
| 5 | $47.84 | 2,625 | $126K | 1.1% |
| 6 | $47.84 | 2,625 |
| $126K |
| 1.1% |
| 7 | $47.85 | 3,510 | $168K | 1.4% |
| 8 | $47.85 | 3,510 | $168K | 1.4% |
| Total | $46.94 avg | 250,000 | $11.7M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |